10
Views
0
CrossRef citations to date
0
Altmetric
Biomedical Science in Brief

Potential risk of patient misclassification using a point-of-care testing kit for urine drugs of abuse

&
Pages 218-220 | Published online: 12 Feb 2018

References

  • George S, Braithwaite RA. Use of on-site testing for drugs of abuse. Clin Chem 2002; 48: 1639–46.
  • Bowker R, Green A, Bonham JR. Guidelines for the investigation and management of a reduced level of consciousness in children: implications for clinical biochemistry laboratories. Ann Clin Biochem 2007; 44 (Pt 6): 506–11. Erratum in: Ann Clin Biochem 2008; 45 (Pt 2): 227–8.
  • Quantum Diagnostics. One-step multidrug screen test panel instructions. Waltham Abbey, UK: Quantum Diagnostics, 2005.
  • Medical Devices Agency. Management and use of IVD point of care test devices. MDA DB 2002 (3). London: Medical Devices Agency, 2002.
  • Institute of Biomedical Science. Point-of-care testing (near-patient testing): guidance on the involvement of the clinical laboratory (Pr/07.04). London: IBMS, 2004.
  • Freedman DB. Clinical governance implications for point-of-care testing. Ann Clin Biochem 2002; 39 (Pt 5): 421–3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.